The groundbreaking therapy of the medication represents a exciting breakthrough in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide119745.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69055275